Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric K. Peden, MD, Imran T

Slides:

Advertisements

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Advertisements

Endovascular management of transplant renal artery stenosis

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Endovascular management of transplant renal artery stenosis

One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease Corey A. Kalbaugh, MS,

Jason W. Christie, MD, Thomas D. Conlee, MD, Timothy E

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study Henrik.

Hybrid thoracic endovascular aortic repair: Pushing the envelope

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation Thomas M. Loh,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Mark G. Davies, MD, PhD, MBA, Wael E. Saad, MD, Jean X

Ali F. AbuRahma, MD Journal of Vascular Surgery

A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.

Louis L. Nguyen, MD, MBA, MPH Journal of Vascular Surgery

Incorporating simulation in vascular surgery education

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

The first operation on the profunda femoris artery

Supraceliac aortorenal bypass

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Paul B

Tommaso Lupattelli, MD, Giovanni Nano, MD, Luigi Inglese, MD

Regulatory TEVAR clinical trials

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Systematic review and meta-analysis of postcarotid endarterectomy hypertension after eversion versus conventional carotid endarterectomy Serdar Demirel,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Clopidogrel use before renal artery angioplasty with/without stent placement resulted in tertiary procedure risk reduction Albeir Y. Mousa, MD, Mike.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Outcomes of reinterventions after subintimal angioplasty

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Update in preoperative risk assessment in vascular surgery patients

W. Anthony Lee, MD, Peter R. Nelson, MD, Scott A

Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.

Thomas A. Simone, MD, Benjamin S. Brooke, MD, PhD, Philip P

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Peter Neglén, MD, PhD, Kathryn C. Hollis, BA, Seshadri Raju, MD

Outcomes of renal artery angioplasty and stenting using low-profile systems Brian W. Nolan, MD, Marc L. Schermerhorn, MD, Erin Rowell, MD, Richard J.

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia Kevin E. Todd, BS, Sadaf S. Ahanchi, MD, Christian.

Ten-year experience with renal artery in-stent stenosis

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Prolonged renal artery occlusion after endovascular aneurysm repair: Endovascular rescue and renal function salvage Nasim Hedayati, MD, Peter H. Lin,

Reply Journal of Vascular Surgery

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Eric K

Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: Long-term results Jean-Paul P.M. de Vries,

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Radiation arteritis: A contraindication to carotid stenting?

Javier G. Jimenez, MD, Thomas S. Huber, MD, PhD, C

The influence of metabolic syndrome on hemodialysis access patency

Clinton D. Protack, MD, Andrew M. Bakken, MD, Jiaqiong Xu, PhD, Wael A

Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience Elaine Yutan, MD, David.

Endoscopic vein harvest for infrainguinal arterial bypass

Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff Christopher J. Abularrage,

Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era Heather.

Christopher L. Skelly, MD, Katherine Gallagher, BS, Ronald M

Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

Fibromuscular dysplasia with multiple visceral artery involvement

Endovascular brachytherapy for renal artery in-stent restenosis

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Early and long-term results of percutaneous transluminal angioplasty of the lower abdominal aorta Stéphane Elkouri, MD, Gilles Hudon, MD, Philippe Demers,

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric K. Peden, MD, Imran T. Mohiuddin, MD, Joseph J. Naoum, MD, Alan B. Lumsden, MD Journal of Vascular Surgery Volume 48, Issue 4, Pages 865-871 (October 2008) DOI: 10.1016/j.jvs.2008.05.030 Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Fig A, Life-table analysis of primary and assisted primary patency of the renal vessels intervened on for symptomatic fibromuscular dysplasia. B, Life-table analysis of freedom from restenosis. C, Life-table analysis of freedom from recurrent hypertension. Recurrence was defined as a recurrence of diastolic blood pressure >90 mm Hg or systolic blood pressure >140 mm Hg or a >20% increase of postprocedural baseline diastolic blood pressure that was not treatable by repeat angioplasty. Values are mean ± standard error of the mean. The number at risk at each time interval is shown below each figure. Journal of Vascular Surgery 2008 48, 865-871DOI: (10.1016/j.jvs.2008.05.030) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions